Latest CTSO reports update at 2023-11-09: 2023-Q32022-Q42022-Q3
Cytosorbents Corporation logo
Cytosorbents Corporation CTSO
$ 0.93 5.68%

Cytosorbents Corporation Financial Ratios 2011-2024 | CTSO

Annual Financial Ratios Cytosorbents Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.8 -6.6 -52.0 -8.3 -13.2 -24.8 -11.8 -11.8 -12.4 -14.1 -5.7 -4.4

P/S

16.8 15.0 34.1 6.4 10.1 13.9 14.8 19.9 28.0 27.3 15.5 661.8

EPS

-0.0 -0.2 -0.2 -0.6 -0.6 -0.3 -0.5 -0.3 -1.3 -0.0 -0.0 -0.1

EV (Enterprise Value)

163 M 136 M 347 M 172 M 220 M 206 M 146 M 93.3 M 116 M 82.2 M 34 M 24.5 M

EBITDA per Share

-0.13 -0.2 -0.05 -0.57 -0.495 -0.349 -0.445 -0.369 -0.502 -0.492 -0.433 -0.686

EV/EBITDA

-4.8 -34.8 -8.9 -14.1 -21.0 -12.4 -9.8 -15.5 -14.1 -5.8 -5.3

PEG

-0.1 -0.13 7.39 1.16 0.18 -0.78 0.28 -0.16 0.17 6.92 -0.14 1.45

P/B

4.4 2.6 5.1 46.8 13.4 20.4 -297.7 11.6 29.1 -4.6 -1.8 75.0

P/CF

-5.6 -11.5 -72.5 -8.8 -18.4 -25.8 -19.3 -9.9 -16.4 -17.8 -5.7 -6.2

ROE %

-92.76 -39.24 -9.89 -563.65 -101.63 -82.44 2518.28 -99.04 -235.21 32.79 31.51 -1721.93

ROA %

-51.89 -27.43 -8.71 -70.36 -52.56 -35.10 -123.16 -72.25 -110.07 -115.62 -109.71 -258.26

ROCE %

-17.97 -15.28 -3.33 -108.76 -59.46 -60.55 -318.85 -113.31 -183.66 -480.55 -276.46 -746.19

Current Ratio

2.3 3.3 8.4 2.1 4.3 2.6 1.3 3.2 1.7 1.1 1.4 1.1

DSO

198.0 163.9 146.9 65.4 64.0 53.1 54.9 49.4 72.5 68.3 14.1 365.0

DIO

107.6 122.9 79.1 104.8 40.6 52.6 77.0 196.4 92.0 46.9 780.0 13377.8

DPO

58.3 76.7 64.0 132.3 95.8 103.6 122.8 112.9 119.4 150.2 915.3 20955.2

Operating Cycle

305.6 286.8 226.0 170.1 104.6 105.8 131.9 245.9 164.5 115.1 794.1 13742.8

Cash Conversion Cycle

247.3 210.1 162.0 37.9 8.8 2.1 9.1 132.9 45.0 -35.0 -121.2 -7212.4

All numbers in USD currency

Quarterly Financial Ratios Cytosorbents Corporation

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.21 -0.14 -0.17 - -0.28 -0.25 -0.21 -0.25 -0.15 -0.11 -0.1 - -0.02 -0.08 -0.1 -0.13 -0.21 -0.11 -0.15 -0.17 -0.1 -0.19 -0.1 -0.12 -0.07 -0.07 -0.06 -0.19 -0.09 -0.12 -0.07 -0.08 -0.11 0.06 -0.19 -0.84 -0.22 -0.27 -0.2 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01

EBITDA per Share

- - -0.17 - -0.19 -0.19 -0.17 -0.22 -0.11 -0.11 -0.06 -0.06 -0.04 -0.08 -0.07 -0.17 -0.16 -0.1 -0.13 -0.18 -0.08 -0.13 -0.1 -0.13 -0.07 -0.08 -0.06 -0.18 -0.08 -0.1 -0.08 -0.09 -0.08 -0.09 -0.11 -0.12 -0.11 -0.11 -0.11 - - -0.01 -0.01 - - -0.01 -0.01 - -0.01 -0.01 -0.01

ROE %

-131.67 -113.18 -110.52 -70.22 -85.10 -63.00 -46.41 -35.63 -21.61 -13.60 -10.93 -9.89 -124.58 -324.96 -425.12 -563.65 -480.01 -296.32 -226.91 -101.63 -100.39 -102.66 -85.19 -82.44 -418.59 -562.18 88.62 490.81 831.94 960.87 344.43 -100.35 -225.73 -228.86 -293.10 -260.25 -102.42 -57.85 -1.16 28.10 33.71 32.55 31.64 26.89 -516.21 -1064.92 -1495.23 -1345.94 -543.10 -421.30 -381.53

ROA %

-63.40 -63.67 -62.70 -41.13 -51.53 -27.90 -32.67 -26.66 -17.02 -11.21 -9.64 -8.71 -22.38 -46.59 -56.36 -70.36 -71.73 -55.38 -59.45 -50.33 -47.59 -47.32 -37.50 -35.10 -72.66 -86.70 -110.51 -123.13 -94.99 -97.72 -53.97 -76.94 -178.35 -170.75 -205.38 -174.98 -74.94 -81.10 -94.18 -99.09 -118.61 -114.29 -110.67 -93.61 -175.06 -236.99 -268.82 -201.87 -81.46 -63.19 -57.22

ROCE %

-23.04 -46.08 -63.65 -54.67 -69.95 -54.56 -43.61 -33.25 -21.29 -16.11 -13.65 -13.09 -168.67 -330.84 -432.87 -555.12 -429.19 -280.56 -199.09 -92.03 -96.13 -101.06 -99.04 -95.91 -400.55 -539.93 49.63 505.67 824.91 959.04 365.06 -108.83 -127.98 -139.23 -146.50 -142.60 -94.79 -51.19 -6.93 26.00 31.17 30.17 29.00 23.04 -183.10 -394.41 -590.48 -583.31 -206.14 -187.38 -189.79

Current Ratio

1.6 1.9 2.0 2.3 2.7 - 3.0 3.3 3.9 4.1 8.6 8.4 8.4 8.4 8.4 1.1 1.1 1.1 1.1 2.0 2.0 2.0 2.0 1.7 1.7 1.7 1.7 1.2 1.2 0.9 0.9 3.7 3.7 3.7 - - - - - 1.3 1.3 1.9 4.1 1.6 1.6 1.6 1.6 1.2 1.2 1.2 1.2

DSO

68.4 60.8 54.0 - 27.9 24.6 47.8 41.3 51.4 40.9 43.8 39.4 44.6 48.1 50.4 54.9 66.9 65.4 73.9 59.2 62.6 62.5 57.0 43.3 52.6 56.4 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

DIO

71.5 50.6 59.2 - 36.0 70.0 204.6 - 152.2 114.4 95.9 - 84.4 75.1 91.6 - 113.7 105.2 77.3 - 37.0 42.6 47.4 - 47.9 49.0 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

89.4 78.2 53.1 - 23.8 62.0 152.9 - 102.3 64.7 58.2 - 57.9 51.5 74.1 - 109.7 101.4 92.5 - 66.0 75.9 79.5 - 74.9 76.6 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

139.9 111.4 113.3 - 63.9 94.5 252.3 41.3 203.6 155.3 139.7 39.4 129.1 123.1 142.0 54.9 180.6 170.6 151.2 59.2 99.7 105.1 104.4 43.3 100.5 105.4 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

Cash Conversion Cycle

50.5 33.2 60.2 - 40.0 32.5 99.5 41.3 101.3 90.6 81.4 39.4 71.1 71.6 67.9 54.9 70.9 69.1 58.7 59.2 33.6 29.2 24.9 43.3 25.6 28.8 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

All numbers in USD currency